Neesha Rockwood

Summary

Country: UK

Publications

  1. ncbi Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir
    Neesha Rockwood
    Department of HIV Medicine, Chelsea and Westminster Hospital, London, UK
    AIDS 25:1671-3. 2011

Detail Information

Publications1

  1. ncbi Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir
    Neesha Rockwood
    Department of HIV Medicine, Chelsea and Westminster Hospital, London, UK
    AIDS 25:1671-3. 2011
    ..When choosing a boosted protease inhibitor, ATZ/r renal stones should be considered as a potential comorbidity...